$2.63 -0.02 (-0.75%)
11/25/2009 4:00 PM

Hansen Medical, Inc. (HNSN)

CAPS Rating: 4 out of 5

The Company develops and manufactures a new generation of medical robotics designed for accurate positioning, manipulation and stable control of catheters and catheter-based technologies.

Results 1 - 20 of 100 1 2 3 4 5 Next »

Recs

0
Member Avatar neurite001 (68.16) Submitted: 11/13/2009 11:01:37 AM : Outperform Start Price: $2.86 HNSN Score: -9.57

Future of surgery. Entering with caution.

Recs

0
Member Avatar 08PortfolioModel (< 20) Submitted: 9/17/2009 1:34:53 PM : Outperform Start Price: $3.12 HNSN Score: -17.78

Current 3.12, Sept 17 09. Limit 3.06

Recs

0
Member Avatar CaptBS (94.63) Submitted: 9/11/2009 11:38:09 AM : Outperform Start Price: $3.34 HNSN Score: -28.06

Pick from EV38's blog and fransgeraedts

Recs

5
Member Avatar DRSTOCKENSTEIN (< 20) Submitted: 8/5/2009 4:11:16 PM : Outperform Start Price: $3.80 HNSN Score: -41.79

stock is a serious gift at 4 a share.As a thoracic surgeon I can personally attest to the sensei system's magnificent performance.One is also assured by Dr, Moll's guidance and assurance of the continual updating and improvements going forward.I.m all in.

Recs

1
Member Avatar Bromidiom (< 20) Submitted: 7/30/2009 9:51:36 AM : Underperform Start Price: $3.77 HNSN Score: +42.39

> The Sensei is a dangerous piece of equipment for patients, leading to 17-19% complication rates.

> Dr. Fred Moll has lost all credibility after promising "slam dunk" guidance of 53-60 systems in 2009, after only delivering 3 in Q2 (conveniently after they pushed a secondary in April, have you.)

> Hansen's gross margins have eroded to close to 0% as ASPs have collapsed due to the lack of a value proposition.

> Hansen needs to completely restructure and reengineer its product for use in electrophysiology to be adopted clinically. A 17F sheath is too big for the vasculature, in particular, the femoral artery.

> Hansen has suffered the loss of talent, with spontaneous resignations from the President and COO, Gary Restani, to members of the board and key engineering talent.

Recs

1
Member Avatar rockfishcc8 (< 20) Submitted: 7/14/2009 2:00:58 PM : Outperform Start Price: $2.70 HNSN Score: -26.20

The new health care plan will undoubtably return Hansen to double digit numbers.They had a bad last quarter,but almost everyone did.Look for Hansen to clean up all debt and get a huge push from the health care plan

Recs

0
Member Avatar dragonmonkey2 (35.05) Submitted: 6/20/2009 3:53:12 PM : Outperform Start Price: $5.00 HNSN Score: -70.21

Alternate profile for stocks I want to track seperately.

Recs

0
Member Avatar jlmjlm77 (99.79) Submitted: 5/11/2009 12:29:00 PM : Outperform Start Price: $6.67 HNSN Score: -83.35

Medical robots, inside buying

Recs

0
Member Avatar billisutra (64.19) Submitted: 5/8/2009 8:54:09 AM : Outperform Start Price: $7.29 HNSN Score: -86.21

won the lawsuit, good positioning

Recs

0
Member Avatar heath50 (47.73) Submitted: 5/7/2009 11:32:58 AM : Outperform Start Price: $6.85 HNSN Score: -84.65

Undervalued, just won $36MM suit v. LUNA

Recs

0
Member Avatar olegmi (< 20) Submitted: 5/7/2009 10:40:33 AM : Outperform Start Price: $6.64 HNSN Score: -83.23

Today they signed a deal with GE Healthcare. It will boost their sales all over the world.

Recs

0
Member Avatar stevethelimey (< 20) Submitted: 5/3/2009 10:44:41 PM : Outperform Start Price: $5.50 HNSN Score: -79.28

Early days, reminiscent of ISRG. Several insiders have recently brought lots of shares

Recs

0
Member Avatar tsperbeck (98.76) Submitted: 4/28/2009 1:33:43 PM : Outperform Start Price: $4.86 HNSN Score: -76.64

Indsider buying, RB.

Recs

0
Member Avatar Turbolover (79.06) Submitted: 4/28/2009 9:40:33 AM : Outperform Start Price: $4.89 HNSN Score: -78.44

Rule Breaker, beat down by the current market.

Recs

0
Member Avatar Babachrono (98.70) Submitted: 4/27/2009 2:59:12 AM : Underperform Start Price: $5.10 HNSN Score: +79.68

22% insider ownership and only 28% institutional. They've had negative EPS the last 7 quarters and its projected to continue for the future 2-5…they just reduced guidance for 2009, even further delaying profitability. Yes its far off its 52 week high and there has been lots of insider buying lately. They've been burning through cash almost as fast as the US government, and just had to offer up some stock, diluting shares, because they need more. Hospitals aren't going to be spending like crazy anytime soon. I think they are too far behind with other companies already out with safe and effective products, I don't think hansen can make it. Going bye bye.

Recs

1
Member Avatar Trimalerus (99.66) Submitted: 4/3/2009 8:40:21 PM : Outperform Start Price: $4.30 HNSN Score: -73.82

Good price, near 52 week low. Robotics & less invasive surgery are two medical trends that will continue to grow IMHO. 3D Imaging is also a high growth market. Well run company at a great discount, I'd say it's a obvious buy.

Recs

0
Member Avatar djturn3 (29.99) Submitted: 3/25/2009 1:54:22 PM : Outperform Start Price: $3.50 HNSN Score: -64.36

Assets have grown considerably while the liabilities only increase slightly. Like the cash on hand as well.

Recs

0
Member Avatar lagunabb (< 20) Submitted: 12/4/2008 12:08:15 PM : Underperform Start Price: $7.86 HNSN Score: +98.36

patient died recently during Hansen procedure

Recs

1
Member Avatar orenjikun (< 20) Submitted: 11/5/2008 12:40:21 PM : Underperform Start Price: $11.00 HNSN Score: +93.13

With nearly 1/5 procedures with the sensei system having sometimes life-threatening complications and top executives of the company threatening to split (and go somewhere else)... this company and it's product seems to be defective. I wouldn't put my money on this company.

Recs

0
Member Avatar DarkToast (98.61) Submitted: 11/5/2008 11:38:28 AM : Outperform Start Price: $11.00 HNSN Score: -92.04

National health care plan incoming....

Results 1 - 20 of 100 1 2 3 4 5 Next »

Featured Broker Partners